Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis.
Hao ChenMasashi IshiharaNobuyuki HoritaHiroki KazahariRyusuke OchiaiShigeru TanzawaTakeshi HondaYasuko IchikawaKiyotaka WatanabeNobuhiko SekiPublished in: Cancers (2021)
Adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma improved the outcome after surgery. The SCLC regimen showed better survival than the NSCLC regimen as palliative chemotherapy.